IQVIA Holdings Inc. (IQV)
USD 190.97
(-2.88%)
USD 190.97
(-2.88%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 1.35 Billion USD | 24.47% |
| 2022 | 1.09 Billion USD | 12.94% |
| 2021 | 966 Million USD | 246.24% |
| 2020 | 279 Million USD | 46.07% |
| 2019 | 191 Million USD | -26.25% |
| 2018 | 259 Million USD | -80.21% |
| 2017 | 1.3 Billion USD | 1038.26% |
| 2016 | 115 Million USD | -70.3% |
| 2015 | 387.2 Million USD | 8.65% |
| 2014 | 356.38 Million USD | 57.28% |
| 2013 | 226.59 Million USD | 27.62% |
| 2012 | 177.54 Million USD | -26.56% |
| 2011 | 241.77 Million USD | 50.55% |
| 2010 | 160.59 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 288 Million USD | -38.59% |
| 2024 Q2 | 363 Million USD | 26.04% |
| 2024 Q3 | 285 Million USD | -21.49% |
| 2023 Q4 | 469 Million USD | 54.79% |
| 2023 Q3 | 303 Million USD | 2.02% |
| 2023 FY | 1.35 Billion USD | 24.47% |
| 2023 Q1 | 289 Million USD | 27.31% |
| 2023 Q2 | 297 Million USD | 2.77% |
| 2022 Q4 | 227 Million USD | -19.79% |
| 2022 Q3 | 283 Million USD | 10.55% |
| 2022 Q2 | 256 Million USD | -21.23% |
| 2022 FY | 1.09 Billion USD | 12.94% |
| 2022 Q1 | 325 Million USD | 2.2% |
| 2021 Q1 | 212 Million USD | 78.15% |
| 2021 Q2 | 175 Million USD | -17.45% |
| 2021 Q3 | 261 Million USD | 49.14% |
| 2021 Q4 | 318 Million USD | 21.84% |
| 2021 FY | 966 Million USD | 246.24% |
| 2020 Q4 | 119 Million USD | 17.82% |
| 2020 Q3 | 101 Million USD | 539.13% |
| 2020 Q2 | -23 Million USD | -128.05% |
| 2020 Q1 | 82 Million USD | 412.5% |
| 2020 FY | 279 Million USD | 46.07% |
| 2019 Q2 | 60 Million USD | 3.45% |
| 2019 FY | 191 Million USD | -26.25% |
| 2019 Q4 | 16 Million USD | -71.93% |
| 2019 Q3 | 57 Million USD | -5.0% |
| 2019 Q1 | 58 Million USD | -15.94% |
| 2018 Q4 | 69 Million USD | 15.0% |
| 2018 Q2 | 61 Million USD | -11.59% |
| 2018 FY | 259 Million USD | -80.21% |
| 2018 Q1 | 69 Million USD | -93.59% |
| 2018 Q3 | 60 Million USD | -1.64% |
| 2017 Q2 | 62 Million USD | -16.22% |
| 2017 Q4 | 1.07 Billion USD | 1122.73% |
| 2017 Q1 | 74 Million USD | 141.57% |
| 2017 Q3 | 88 Million USD | 41.94% |
| 2017 FY | 1.3 Billion USD | 1038.26% |
| 2016 FY | 115 Million USD | -70.3% |
| 2016 Q3 | 100 Million USD | 16.28% |
| 2016 Q2 | 86 Million USD | -19.63% |
| 2016 Q1 | 107 Million USD | 2.32% |
| 2016 Q4 | -178 Million USD | -278.0% |
| 2015 Q1 | 86.39 Million USD | -2.29% |
| 2015 Q4 | 104.57 Million USD | -6.03% |
| 2015 Q3 | 111.28 Million USD | 31.0% |
| 2015 Q2 | 84.95 Million USD | -1.67% |
| 2015 FY | 387.2 Million USD | 8.65% |
| 2014 Q3 | 92.65 Million USD | 8.85% |
| 2014 Q2 | 85.12 Million USD | -5.61% |
| 2014 Q1 | 90.18 Million USD | 23.55% |
| 2014 FY | 356.38 Million USD | 57.28% |
| 2014 Q4 | 88.42 Million USD | -4.56% |
| 2013 Q4 | 72.99 Million USD | 9.33% |
| 2013 Q1 | 48.3 Million USD | 38.13% |
| 2013 FY | 226.59 Million USD | 27.62% |
| 2013 Q2 | 38.51 Million USD | -20.27% |
| 2013 Q3 | 66.76 Million USD | 73.35% |
| 2012 FY | 177.54 Million USD | -26.56% |
| 2012 Q1 | 43.27 Million USD | 0.0% |
| 2012 Q4 | 34.97 Million USD | -32.87% |
| 2012 Q2 | 47.2 Million USD | 9.08% |
| 2012 Q3 | 52.09 Million USD | 10.37% |
| 2011 FY | 241.77 Million USD | 50.55% |
| 2010 FY | 160.59 Million USD | 0.0% |
| 2001 Q3 | 283 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Agilent Technologies, Inc. | 1.24 Billion USD | -9.516% |
| Charles River Laboratories International, Inc. | 474.62 Million USD | -186.121% |
| Quest Diagnostics Incorporated | 854 Million USD | -59.016% |
| Danaher Corporation | 4.76 Billion USD | 71.495% |
| Enzo Biochem, Inc. | -26.07 Million USD | 5307.455% |
| Laboratory Corporation of America Holdings | 418 Million USD | -224.88% |
| Mettler-Toledo International Inc. | 788.77 Million USD | -72.165% |
| Qiagen N.V. | 341.3 Million USD | -297.887% |
| Revvity, Inc. | 693.09 Million USD | -95.933% |
| Thermo Fisher Scientific Inc. | 5.99 Billion USD | 77.348% |
| Waters Corporation | 642.23 Million USD | -111.449% |